Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 5;12(9):2027.
doi: 10.3390/biomedicines12092027.

Are Sirtuins 1 and 2 Relevant Players in Relapsing-Remitting Multiple Sclerosis?

Justyna Chojdak-Łukasiewicz  1 , Anna Bizoń  2 , Aleksandra Kołtuniuk  3 , Marta Waliszewska-Prosół  1 , Sławomir Budrewicz  1 , Agnieszka Piwowar  2 , Anna Pokryszko-Dragan  1
Affiliations

Are Sirtuins 1 and 2 Relevant Players in Relapsing-Remitting Multiple Sclerosis?

Justyna Chojdak-Łukasiewicz et al. Biomedicines. .

Abstract

SIRTs were demonstrated to play an important role in inflammatory, degenerative, and metabolic alterations, constituting the background of the central nervous system. Thus, they seem to be an appropriate object of investigation (as potential biomarkers of disease activity and/or novel therapeutic targets) in multiple sclerosis (MS), which has a complex etiology that comprises a cross-talk between all these processes. The aim of this study was to evaluate the levels of SIRT1 and SIRT2 in the serum of patients with the relapsing-remitting type of MS (RRMS), as well as their relationships with various aspects of MS-related disability.

Methods: A total of 115 patients with RRMS (78 women, 37 men, mean age 43 ± 9.9) and 39 healthy controls were included in the study. SIRT1 and SIRT2 were detected in the serum using the enzyme-linked immunoassay (ELISA) method. In the RRMS group, relationships were investigated between the SIRT 1 and 2 levels and the demographic data, MS-related clinical variables, and the results of tests evaluating fatigue, sleep problems, cognitive performance, autonomic dysfunction, and depression.

Results: The levels of SIRT1 and SIRT2 in RRMS patients were significantly lower than in the controls (11.14 vs. 14. 23, p = 0.04; 8.62 vs. 14.2, p < 0.01). In the RRMS group, the level of both SIRTs was higher in men than in women (15.7 vs. 9.0; 11.3 vs. 7.3, p = 0.002) and showed a significant correlation with the degree of disability (R = -0.25, p = 0.018). No other relationships were found between SIRT levels and the analyzed data.

Conclusions: The serum levels of SIRT1 and 2 were decreased in the RRMS patients (especially in the female ones) and correlated with the degree of neurological deficit. The role of SIRTs as biomarkers of disease activity or mediators relevant for "invisible disability" in MS warrants further investigation.

Keywords: SIRT1; SIRT2; biomarkers; disability; multiple sclerosis; sirtuins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Concentration of SIRT 1 in the study group.
Figure 2
Figure 2
Concentration of SIRT 2 in the study group.
See this image and copyright information in PMC

References

    1. Kratz E.M., Sołkiewicz K., Kubis-Kubiak A., Piwowar A. Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators. Int. J. Mol. Sci. 2021;22:630. doi: 10.3390/ijms22020630. - DOI - PMC - PubMed
    1. Foolad F., Khodagholi F., Javan M. Sirtuins in Multiple Sclerosis: The crossroad of neurodegeneration, autoimmunity and metabolism. Mult. Scler. Relat. Disord. 2019;34:47–58. doi: 10.1016/j.msard.2019.06.004. - DOI - PubMed
    1. Fujita Y., Yamashita T. Sirtuins in Neuroendocrine Regulation and Neurological Diseases. Front. Neurosci. 2018;12:778. doi: 10.3389/fnins.2018.00778. - DOI - PMC - PubMed
    1. Elbaz E.M., Senousy M.A., El-Tanbouly D.M., Sayed R.H. Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation. Toxicol. Appl. Pharmacol. 2018;352:153–161. doi: 10.1016/j.taap.2018.05.035. - DOI - PubMed
    1. Chojdak-Łukasiewicz J., Bizoń A., Waliszewska-Prosół M., Piwowar A., Budrewicz S., Pokryszko-Dragan A. Role of Sirtuins in Physiology and Diseases of the Central Nervous System. Biomedicines. 2022;10:2434. doi: 10.3390/biomedicines10102434. - DOI - PMC - PubMed

LinkOut - more resources